Blueprint Medicines Corporation

LSE:0HOJ Stock Report

Market Cap: US$6.3b

Blueprint Medicines Balance Sheet Health

Financial Health criteria checks 4/6

Blueprint Medicines has a total shareholder equity of $313.1M and total debt of $647.8M, which brings its debt-to-equity ratio to 206.9%. Its total assets and total liabilities are $1.2B and $886.5M respectively.

Key information

206.9%

Debt to equity ratio

US$647.78m

Debt

Interest coverage ration/a
CashUS$734.17m
EquityUS$313.15m
Total liabilitiesUS$886.50m
Total assetsUS$1.20b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0HOJ's short term assets ($854.8M) exceed its short term liabilities ($257.7M).

Long Term Liabilities: 0HOJ's short term assets ($854.8M) exceed its long term liabilities ($628.8M).


Debt to Equity History and Analysis

Debt Level: 0HOJ has more cash than its total debt.

Reducing Debt: 0HOJ's debt to equity ratio has increased from 0% to 206.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0HOJ has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 0HOJ has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies